LncRNA Transcriptional Mechanisms of Coronary Artery Disease Risk
冠状动脉疾病风险的 LncRNA 转录机制
基本信息
- 批准号:10327641
- 负责人:
- 金额:$ 39.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-18 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesBiologicalBiological AssayBlood VesselsCardiovascular DiseasesCell physiologyCellsChromatinClustered Regularly Interspaced Short Palindromic RepeatsCodeComplexCoronary ArteriosclerosisCoronary arteryCoupledDevelopmentDiseaseDisease PathwayEpigenetic ProcessEtiologyEvaluationExonsGene ExpressionGenesGeneticGenetic RiskGenetic TranscriptionGenetic VariationGenomeGenomicsGoalsHistonesHumanHuman GenomeIn VitroInflammatoryInheritedLinkMapsMediatingMethodsModificationMolecularNucleic Acid Regulatory SequencesPathway AnalysisPathway interactionsPhenotypePlayPopulationPost-Translational Protein ProcessingProcessProteinsQuantitative Trait LociRNARegulationResearchRiskRisk AssessmentRisk FactorsRoleScientistSignal PathwaySignal TransductionSmooth Muscle MyocytesSpecificityStimulusTherapeuticUntranslated RNAVariantVascular DiseasesWorkbasecausal variantcell typedifferential expressiondisorder riskepigenomeepigenomicsexperimental studyfunctional genomicsgenome editinggenome wide association studygenomic datagenomic locushuman diseasein vitro Assayinnovationnovelprogramspublic health relevanceresponsesingle-cell RNA sequencingtraittranscriptome sequencingvascular stress
项目摘要
Therapeutic risk factor modification has provided a significant decrease in coronary artery disease (CAD) in
Western populations, however, significant risk is due to common inherited genetic variation that affects disease
pathways in the vessel wall and remains poorly understood without specific therapies. To further our long-term
goal of characterizing the molecular basis for this genetic risk, we have participated in genome-wide
association studies (GWAS) identifying allelic variation linked to coronary artery disease (CAD) risk, and these
efforts have yielded hundreds of associated loci. However, the majority of identified causal variation resides
outside of protein coding exons, in regulatory regions of the genome that are poorly understood, and further
efforts are required to understand the mechanisms of association and thus disease risk. Our central hypothesis
is that an important subset of disease allelic variation primarily regulates long non-coding RNA (lncRNA)
expression, with this effect modulating causal protein coding gene (pcGene) expression through functional
genomic interactions such as chromosomal looping. Our objective here is to investigate the role these lncRNAs
play in mediating expression of CAD causal pcGenes, and the mechanism by which they accomplish this
function. Our rationale is that lncRNAs serve as a critical intermediary between genetic and epigenetic
signaling, and that elucidating their mechanism of function is a key aspect of understanding CAD risk. To gain
fundamental information regarding the mode of action of these molecules in the context of CAD, we propose to
study human coronary artery smooth muscle cell (HCASMC) lncRNAs. In Aim 1, we will identify lncRNAs
regulated in these cells by disease-related stimuli and that map to CAD GWAS loci. Co-expression network
analyses will connect these lncRNAs to pcGenes, and initiate network and pathway analyses to begin to
establish their biological functional associations. In Aim 2, we will map expression quantitative trait loci variants
(eQTLs) for each of the lncRNAs, using a high-throughput allele-specific expression method that provides
quantification of low abundance RNAs. Discovered lncRNA eQTLs will be investigated to determine whether
they colocalize with CAD GWAS causal variation, as well as genomic molecular trait QTLs. CRISPR genome
editing will be employed to validate the eQTLs, and confirm pcGene identity. In Aim 3, we will employ CRISPR
inhibition and single cell RNA sequencing (PerturbSeq) to map the transcriptional networks regulated by the
disease related lncRNAs, and also investigate their in vitro cellular effects on HCASMC. These studies will be
aided by our extensive work with primary cultured HCASMC characterizing epigenome modification, chromatin
accessibility, and looping, and our efforts to map CAD GWAS causal variants and genes that mediate risk in
this cell type. This work is highly innovative in that it combines unique genomic datasets developed in a highly
disease relevant cell type and significant since it will integrate lncRNAs, their regulatory variation, and
molecular mechanisms into the etiology of CAD risk.
治疗性危险因素调整可显著降低冠心病(CAD)发生率,
然而,西方人群的重大风险是由于共同的遗传基因变异,影响疾病
血管壁中的通路,并且在没有特定疗法的情况下仍然知之甚少。为了促进我们的长期
为了表征这种遗传风险的分子基础,我们参与了全基因组研究。
关联研究(GWAS)确定与冠状动脉疾病(CAD)风险相关的等位基因变异,这些
努力已经产生了数百个相关的基因座。然而,大多数已确定的因果变异存在于
在蛋白质编码外显子之外,在基因组的调控区域中,这些区域知之甚少,并且进一步
需要努力了解相关机制,从而了解疾病风险。我们的核心假设
疾病等位基因变异的一个重要子集主要调节长链非编码RNA(lncRNA),
表达,这种作用通过功能性调节致病蛋白编码基因(pcGene)的表达
基因组相互作用,如染色体环。我们的目标是研究这些lncRNAs在
在介导CAD致病pcGenes表达中的作用,以及它们实现这一点的机制
功能我们的理论基础是lncRNA作为遗传和表观遗传之间的关键中介
信号,阐明其功能机制是理解CAD风险的关键方面。获得
关于这些分子在CAD背景下的作用模式的基本信息,我们建议
研究人冠状动脉平滑肌细胞(HCASMC)lncRNAs。在目标1中,我们将鉴定lncRNA
在这些细胞中由疾病相关刺激调节,并映射到CAD GWAS基因座。共表达网络
分析将这些lncRNA连接到pcGenes,并启动网络和途径分析,以开始
建立它们的生物功能联系。在目标2中,我们将定位表达数量性状基因座变体,
使用高通量等位基因特异性表达方法,对每个lncRNA的eQTL进行检测,该方法提供了
低丰度RNA的定量。将研究发现的lncRNA eQTL以确定是否
它们与CAD GWAS因果变异以及基因组分子性状QTL共定位。CRISPR基因组
编辑将用于验证eQTL,并确认pcGene身份。在目标3中,我们将使用CRISPR
抑制和单细胞RNA测序(PerturbSeq)来绘制由转录调控的转录网络。
疾病相关的lncRNA,并研究其对HCASMC的体外细胞作用。这些研究报告将
在我们对表征表观基因组修饰的原代培养的HCASMC的大量工作的帮助下,
可及性和循环,以及我们努力绘制CAD GWAS因果变异和介导风险的基因,
这种细胞类型。这项工作是高度创新的,因为它结合了独特的基因组数据集,
疾病相关的细胞类型和重要的,因为它将整合lncRNA,它们的调控变异,
分子机制的研究进展。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Single-cell transcriptome dataset of human and mouse in vitro adipogenesis models.
人类和小鼠体外脂肪形成模型的单细胞转录组数据集。
- DOI:10.1101/2023.03.27.534456
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Li,Jiehan;Jin,Christopher;Gustafsson,Stefan;Rao,Abhiram;Wabitsch,Martin;Park,ChongY;Quertermous,Thomas;Bielczyk-Maczynska,Ewa;Knowles,JoshuaW
- 通讯作者:Knowles,JoshuaW
Environment-Sensing Aryl Hydrocarbon Receptor Inhibits the Chondrogenic Fate of Modulated Smooth Muscle Cells in Atherosclerotic Lesions.
- DOI:10.1161/circulationaha.120.045981
- 发表时间:2020-08-11
- 期刊:
- 影响因子:37.8
- 作者:Kim JB;Zhao Q;Nguyen T;Pjanic M;Cheng P;Wirka R;Travisano S;Nagao M;Kundu R;Quertermous T
- 通讯作者:Quertermous T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS QUERTERMOUS其他文献
THOMAS QUERTERMOUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS QUERTERMOUS', 18)}}的其他基金
Molecular mechanisms of vascular calcification and their connection to coronary disease risk
血管钙化的分子机制及其与冠心病风险的关系
- 批准号:
10673742 - 财政年份:2022
- 资助金额:
$ 39.1万 - 项目类别:
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies: Administrative Supplement (INCLUDE)
阐明多基因扩张型心肌病的基因型-表型关系:行政补充(包括)
- 批准号:
10404723 - 财政年份:2021
- 资助金额:
$ 39.1万 - 项目类别:
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.
通过研究芳基碳氢化合物受体途径来识别烟草与遗传的相互作用。
- 批准号:
10207112 - 财政年份:2021
- 资助金额:
$ 39.1万 - 项目类别:
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.
通过研究芳基碳氢化合物受体途径来识别烟草与遗传的相互作用。
- 批准号:
10372147 - 财政年份:2021
- 资助金额:
$ 39.1万 - 项目类别:
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk
PDGFD 调节转录网络以调节平滑肌细胞转变和冠状动脉疾病风险
- 批准号:
10593934 - 财政年份:2021
- 资助金额:
$ 39.1万 - 项目类别:
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.
通过研究芳基碳氢化合物受体途径来识别烟草与遗传的相互作用。
- 批准号:
10591597 - 财政年份:2021
- 资助金额:
$ 39.1万 - 项目类别:
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk
PDGFD 调节转录网络以调节平滑肌细胞转变和冠状动脉疾病风险
- 批准号:
10172666 - 财政年份:2021
- 资助金额:
$ 39.1万 - 项目类别:
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk
PDGFD 调节转录网络以调节平滑肌细胞转变和冠状动脉疾病风险
- 批准号:
10385753 - 财政年份:2021
- 资助金额:
$ 39.1万 - 项目类别:
Single Cell Sequencing of Human iPSC-CM Subtype Identity and Function
人类 iPSC-CM 亚型身份和功能的单细胞测序
- 批准号:
9763916 - 财政年份:2019
- 资助金额:
$ 39.1万 - 项目类别:
Genetic and Stem Cell Model of Cardiac Metabolic Disease
心脏代谢疾病的遗传和干细胞模型
- 批准号:
9893900 - 财政年份:2019
- 资助金额:
$ 39.1万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 39.1万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 39.1万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 39.1万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 39.1万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 39.1万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 39.1万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 39.1万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 39.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 39.1万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 39.1万 - 项目类别: